Press release
Intestine Cancer Therapeutics Market Size, Driving Factors, Growth Statistics, Competitive Landscape And Forecast To 2033
Intestine Cancer Therapeutics Market Size
According to The Business Research Company's, The intestine cancer therapeutics market size has grown strongly in recent years. It will grow from $12.8 billion in 2023 to $14 billion in 2024 at a compound annual growth rate (CAGR) of 9.4%. The growth in the historic period can be attributed to advancements in medical research, increased cancer incidence, chemotherapy and radiation therapies, screening and early detection initiatives, genetic and biomarker discoveries.
The intestine cancer therapeutics market size is expected to see strong growth in the next few years. It will grow to $19.36 billion in 2028 at a compound annual growth rate (CAGR) of 8.4%. The growth in the forecast period can be attributed to immunotherapy advancements, precision medicine and personalized therapies, emerging targeted therapies, integration of artificial intelligence (ai), patient-centric approaches. Major trends in the forecast period include liquid biopsy technologies, precision medicine and biomarker research, combination therapies, patient-centric care and supportive therapies, adoption of minimally invasive surgical techniques.
Get The Complete Scope Of The Report @
https://www.thebusinessresearchcompany.com/report/intestine-cancer-therapeutics-global-market-report
Market Drivers and Trends:
The increasing prevalence of hereditary colorectal cancer syndromes is expected to propel the growth of the intestine cancer therapeutics market going forward. Hereditary colorectal cancer syndromes are a group of genetic conditions that increase an individual's risk of developing colorectal cancer (colon or ancer). Hereditary colorectal cancer syndromes play a significant role in intestinal cancer therapeutics, providing information associated with specific genetic mutations that substantially increase the risk of developing colorectal cancer. For instance, in July 2023, according to the World Health Organization, a Switzerland-based intergovernmental organization, by 2040, the prevalence of hereditary colorectal cancer is projected to increase significantly, with an estimated 3.2 million new cases and 1.6 million deaths annually. This represents a 63% increase in new cases and a 73% increase in fatalities compared to the current rates. Therefore, the increasing prevalence of hereditary colorectal cancer syndromes is driving the growth of the intestine cancer therapeutics market.
Major companies operating in the intestine cancer therapeutics market are developing innovative products such as Lonsurf and getting approvals to meet larger customer bases, more sales, and increased revenue. LONSURF is a combination of two drugs, trifluridine and tipiracil, for treating adult patients with metastatic colorectal cancer. For instance, in August 2023, Taiho Oncology Inc., a US-based pharmaceutical company, received approval for Lonsurf from the US Food and Drug Administration. Lonsurf is available as a single oral tablet. Trifluridine works by stopping the growth of cancer cells, while tipiracil helps trifluridine to work longer by preventing it from being broken down by the body. The approval of Lonsurf provides patients with metastatic colorectal cancer and other eligible cancers access to a new treatment option that may improve outcomes and quality of life.
Key Benefits for Stakeholders:
• Comprehensive Market Insights: Stakeholders gain access to detailed market statistics, trends, and analyses that help them understand the current and future landscape of their industry.
• Informed Decision-Making: The reports provide crucial data that support strategic decisions, reducing risks and enhancing business planning.
• Competitive Advantage: With in-depth competitor analysis and market share information, stakeholders can identify opportunities to outperform their competition.
• Tailored Solutions: The Business Research Company offers customized reports that address specific needs, ensuring stakeholders receive relevant and actionable insights.
• Global Perspective: The reports cover various regions and markets, providing a broad view that helps stakeholders expand and operate successfully on a global scale.
Ready to Dive into Something Exciting? Get Your Free Exclusive Sample of Our Research Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=13231&type=smp
Major Key Players of the Market:
Pfizer Inc., Johnson & Johnson Private Limited, Roche Holding AG, AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, Abbott Laboratories, GSK plc., Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Merck KGaA, Mylan N.V., Astellas Pharma Inc., Daiichi Sankyo Company Limited, Eisai Co. Ltd., Boehringer Ingelheim International GmbH, Sun Pharmaceutical Industries Ltd., Ipsen Pharma, Hikma Pharmaceuticals plc, Amneal Pharmaceuticals LLC, Cipla Inc., Aurobindo Pharma Limited, Lupin Limited
Intestine Cancer Therapeutics Market 2024 Key Insights:
• The Intestine Cancer Therapeutics is expected to grow to $19.36 billion in 2028 at a compound annual growth rate (CAGR) of 8.4%.
• Rising Prevalence Of Hereditary Colorectal Cancer Syndromes Fuels Growth In Intestine Cancer Therapeutics Market
• Increasing Focus On Product Approvals To Drive The Revenues
• Asia-Pacific was the largest region in the intestine cancer therapeutics market in 2023
We Offer Customized Report, Click @
https://www.thebusinessresearchcompany.com/customise?id=13231&type=smp
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Intestine Cancer Therapeutics Market Size, Driving Factors, Growth Statistics, Competitive Landscape And Forecast To 2033 here
News-ID: 3667149 • Views: …
More Releases from The Business Research Company
An Overview of Segmentation, Market Dynamics, and Competitive Landscape in the C …
The construction tire market is set for steady expansion over the coming years, driven by evolving industry needs and technological advances. As construction activities increase globally, the demand for robust, efficient, and specialized tires continues to rise. Below, we explore the market's size, key players, emerging trends, and segmentation to provide a comprehensive overview of its current and future trajectory.
Projected Growth and Market Size of the Construction Tire Market
The…
Leading Companies Enhancing Their Presence in the Composite Plastic Roof Shingle …
The composite plastic roof shingle market is poised for significant expansion over the coming years as demand for sustainable and durable roofing solutions continues to rise. With increasing emphasis on eco-friendly construction and long-lasting materials, this sector is attracting attention from both manufacturers and consumers seeking innovative roofing options. Let's explore the market's size, key players, emerging trends, and crucial segments shaping its future.
Forecasted Market Growth and Size for Composite…
Key Strategic Developments and Emerging Changes Shaping the Coffee and Tea Packa …
The coffee and tea packaging film sector is positioned for notable expansion over the coming years, driven by evolving consumer demands and technological advancements. This market's growth is closely tied to shifts toward sustainability, improved packaging functionality, and innovative printing techniques. Let's explore the current market size, key players, significant trends, and segment breakdowns to understand how this industry is shaping up through 2030.
Projected Growth Trajectory of the Coffee and…
Segmentation, Major Trends, and Competitive Overview of the Citrus Bioflavonoids …
The citrus bioflavonoids market is positioned for noteworthy expansion in the coming years, driven by increasing health awareness and innovation in natural ingredients. As consumers seek more effective and clean-label supplements, this sector is set to experience dynamic growth through 2030. Let's examine the market size projections, influential factors, leading companies, emerging trends, and key segments shaping this industry's future.
Projected Market Size and Growth Trajectory of the Citrus Bioflavonoids Market…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
